COMMUNIQUÉS West-GlobeNewswire

NeuroMetrix Reports Publication of New Clinical Studies on DPNCheck
26/06/2018
WALTHAM, Mass., June 26, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported publication of three new clinical studies on DPNCheck ® , a point-of-care device that provides accurate and cost- [...]
electroCore, Inc. Announces Closing of Initial Public Offering
26/06/2018
BASKING RIDGE, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR) today announced the closing of its initial public offering of 5,200,000 shares of common stock at a public offering [...]
UPDATE -- Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
26/06/2018
Company to open corporate headquarters in Minneapolis, MN MINNEAPOLIS, June 26, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic [...]
CyberFuels Completes First Order of EcoFlex 96 to Russia and receives first order of Dynamo Cetane Booster for Costa Rica
26/06/2018
PALM BEACH GARDENS, Fla., June 26, 2018 (GLOBE NEWSWIRE) -- EncounterCare Solutions Inc. (Pink Sheets:ECSL) wholly owned subsidiary CyberFuels Inc. is pleased to announce that it has completed its first order for Russia [...]
Rubicon Organics is an International Cannabis Powerhouse in the Making -- CFN Media
26/06/2018
SEATTLE, WA, June 26, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article [...]
Autolus Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
26/06/2018
Autolus Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares LONDON – 26 June 2018 – Autolus Therapeutics plc (“Autolus”) (NASDAQ: AUTL [...]
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
26/06/2018
Company to open corporate headquarters in Minneapolis, MN MINNEAPOLIS, June 26, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic [...]
First Patient Dosed in Phase 2 Study of PARP/Tankyrase Inhibitor 2X-121 for Metastatic Breast Cancer
26/06/2018
CAMBRIDGE, Mass. and HOERSHOLM, Denmark, June 26, 2018 (GLOBE NEWSWIRE) -- Oncology Venture US Inc., Oncology Venture AB (OV:ST) (“OV”) and Medical Prognosis Institute A/S (MPI:ST) today announced dosing of the first [...]
Admera Health Announces Availability of Psychiatric Specific Report, PGxPsych™, for its PGxOne™ Plus Pharmacogenomics Test
26/06/2018
SOUTH PLAINFIELD, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- Today, Admera Health ( www.admerahealth.com ), announced the availability of a psychiatric specific report for its PGxOne™ Plus pharmacogenomics test. PGxOne™ [...]
WellDoc® Presents Results of an Innovative Economic Analysis Demonstrating Opportunity for Significant Healthcare Cost Savings with the Use of BlueStar®
26/06/2018
Findings Shared During Poster Presentation at the American Diabetes Association’s (ADA) 78th Scientific Sessions BALTIMORE, Md., June 26, 2018 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company [...]
Arch Biopartners Receives $332,750 From the Exercise of Warrants
26/06/2018
TORONTO, June 26, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners, Inc., (Arch or the Company) (TSX-V:ARCH) (OTCQB:ACHFF) a portfolio-based biotechnology company, today announced that it received net proceeds of $332,750 [...]
Photocure ASA: Kjetil Hestdal steps down as CEO
26/06/2018
Oslo, Norway, 26 June 2018: Photocure ASA (OSE: PHO), announces today that President and Chief Executive Officer, Kjetil Hestdal, will step down effective 1 July 2018 as the company is entering a new growth phase with [...]
NSS Labs Chosen as a 2018 Red Herring Top 100 North America Winner
26/06/2018
Company Earns Prestigious Honor for Second Consecutive Year and Advances Mission to Empower Enterprises to Know Where they Stand AUSTIN, Texas, June 26, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and [...]
Keeping Your Vagina Clean, Comfortable, and Happy, with the Newly Designed Patented Smooth Applicator
26/06/2018
Introducing the pHemme® family of products specifically design for the modern women to tackle on today’s feminine hygiene issues. TORONTO, June 26, 2018 (GLOBE NEWSWIRE) -- Not everyone has symptoms when they’ve [...]
Gardez votre vagin propre, confortable et heureux avec l’applicateur lisse redessiné et breveté
26/06/2018
Voici la gamme de produits pHemme® à l’intention de la femme moderne, conçue pour parer aux problèmes d’hygiène féminine d’aujourd’hui. TORONTO, 26 juin 2018 (GLOBE NEWSWIRE) -- Ce ne sont pas toutes les femmes qui [...]
BLVD Centers Begins Trading on Canadian Securities Exchange; Voluntarily Delists From TSX Venture Exchange
26/06/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, June 26, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (“ BLVD ” or the “ Company ”) (CSE:BLVD), in [...]
Valens GroWorks Laser Focused on Quality Control Throughout Supply Chain -- CFN Media
26/06/2018
SEATTLE, June 26, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Sapience Therapeutics, Inc. Selected as a Winner of the JLABS NYC QuickFire Challenge
26/06/2018
HARRISON, N.Y., June 26, 2018 (GLOBE NEWSWIRE) -- Sapience Therapeutics, Inc., a biotechnology company focused on developing peptide therapeutics to address difficult to treat oncology indications, announced today that [...]
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
26/06/2018
TEL AVIV, Israel, June 26, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Pages